Wire Stories
Akron Bio Receives Eligibility Confirmation from PMDA in Japan for the Commercialization of Virus Inactivated Human Fibronectin in Clinical Cell Therapy Manufacturing
BOCA RATON, Fla.–(BUSINESS WIRE)–Akron Bio (�Akron�), a leading supplier of critical inputs for cell and gene therapies, today announced that Japan�s Pharmaceuticals...